動態

• 

  Mary Grace N. Tamio   shared news

  在 August 09 2022 at 09:26 PM 已編輯 public

  Risk factors for poor response to denosumab treatment in Japanese postmenopausal women with osteoporosis
  
  #denosumab #postmenopausal #osteoporosis #journals #articles
  
  For more information | ⬇️

  

  Risk factors for poor response to denosumab treatment in Japanese postmenopausal women with osteoporosis

  Denosumab has been reported to increase bone mineral density (BMD) and suppress fractures, but poor responders are not unc...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 April 05 2022 at 12:40 PM 已編輯 public

  Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
  
  #raloxifenetheraphy #denosumab #postmenopausal #journals #articles
  
  For more information | ⬇️

  

  Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women

  Follow-up raloxifene therapy after denosumab discontinuation resulted in a decrease in bone mass to the pre-denosumab leve...
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 May 19 2021 at 08:21 PM 已編輯 public

  Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?
  
  #denosumab #osteoporosis #sarcopenia #journals
  
  For more information | ⬇️
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享
• 

  Mary Grace N. Tamio   shared news

  在 March 19 2021 at 09:02 PM 已編輯 public

  Zoledronic acid maintains BMD gains after teriparatide, denosumab combination therapy
  
  #zoledronicacid #BMD #teriparatide #denosumab
  
  For more information | ⬇️
  0 0 0 0 0 0 0

  comment 留言

  thumb_upLike

  share 分享